The goals of imaging after neoadjuvant therapy for breast cancer are to monitor the
response to therapy and facilitate surgical planning. MRI has been found to be more …

This meta-analysis aimed to estimate and compare sensitivity, specificity, positive-(PPV) and
negative predictive value (NPV) of magnetic resonance imaging (MRI) for predicting …

MRI of the breast has the highest sensitivity for breast cancer detection among current
clinical imaging modalities and is indispensable for breast imaging practice. While the basis …

Neoadjuvant therapy is increasingly being used to treat early-stage triple-negative and
human epidermal growth factor 2–overexpressing breast cancers, as well as locally …

Simple Summary Neoadjuvant chemotherapy (NACT) indications have expanded from
inoperable locally advanced to early-stage breast cancer. The pivotal role of magnetic …

Reliable early assessment of breast cancer response to neoadjuvant therapy (NAT) would
provide considerable benefit to patient care and ongoing research efforts, and demand for …

Background Achieving pathological complete response (pCR) to neoadjuvant
chemotherapy (NAC) improves survival outcomes for breast cancer patients. Currently …

Objectives To assess whether magnetic resonance imaging (MRI) can identify pre-treatment
differences or monitor early response in breast cancer patients receiving neoadjuvant …

The current state‐of‐the‐art assessment of treatment response in breast cancer is based on
the response evaluation criteria in solid tumors (RECIST). RECIST reports on changes in …

Background Prior studies of the ability of magnetic resonance imaging (MRI) to predict
pathologic response to neoadjuvant chemotherapy have shown conflicting results that vary …